Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A companion study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial

Project: Research project

Project Details


The primary aim is to characterize the longitudinal change on the cognititive, clinical, and biomarker measures used in the A4 trial in ABne individuals in comparison to the ABe A4 placebo arm individuals.
Effective start/end date7/23/1511/30/15


  • University of California, San Diego (59504835 // 5U19AG010483-24)
  • National Institute on Aging (59504835 // 5U19AG010483-24)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.